BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38742149)

  • 1. Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study.
    Song Z; Xing J; Sun Z; Kang X; Li H; Ren G; Wang Y
    Front Surg; 2024; 11():1370702. PubMed ID: 38742149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
    Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
    Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
    Talenfeld AD; Gennarelli RL; Elkin EB; Atoria CL; Durack JC; Huang WC; Kwan SW
    Ann Intern Med; 2018 Jul; 169(2):69-77. PubMed ID: 29946703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
    Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.
    Forbes CM; Rendon RA; Finelli A; Kapoor A; Moore RB; Breau RH; Lacombe L; Kawakami J; Drachenberg DE; Pautler SE; Jewett MMA; Saarela O; Liu Z; Tanguay S; Black PC
    Urol Oncol; 2016 Nov; 34(11):486.e17-486.e23. PubMed ID: 27423824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis.
    Huang R; Zhang C; Wang X; Hu H
    Front Oncol; 2021; 11():680842. PubMed ID: 34178668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of partial nephrectomy and radical nephrectomy for cystic renal cell carcinoma: a SEER-based and retrospective study.
    Lin W; Yang Z; Yan L; Dai J; Fang C; Hao Y; Xu D; Zhang J; Zhao J
    Sci Rep; 2023 May; 13(1):8052. PubMed ID: 37198295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy.
    Alanee S; Nutt M; Moore A; Holland B; Dynda D; Wilber A; El-Zawahry A
    Int Urol Nephrol; 2015 Jun; 47(6):945-50. PubMed ID: 25864101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
    Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
    Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
    Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
    Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate.
    Chung JS; Son NH; Lee SE; Hong SK; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
    J Korean Med Sci; 2018 Oct; 33(43):e277. PubMed ID: 30344463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
    Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.